Results 41 to 50 of about 2,797 (93)

Study protocol and statistical plan for the ICRAKI trial: Intermittent haemodialysis versus continuous renal replacement therapy for severe acute kidney injury in critically ill patients. [PDF]

Crit Care Resusc
Gaudry S, Boubaya M, Louis G, Chaïbi K, Mégarbane B, Bohe J, Desgrouas M, Gele-Decaudin G, Joseph A, de Montmollin E, Camus C, De Prost N, Bailly P, Jaber S, Chudeau N, Lambour A, Robine A, La Combe B, Kimmoun A, Chevrel G, Argaud L, Nicolas J, Thiery G, Faguer S, Jozwiak M, Ricard JD, Contou D, Marzouk M, Chousterman B, Cadiet J, Bureau C, Zaleski ID, Rossignol P, Quenot JP, Queyrat CB, Dreyfuss D.   +35 more
europepmc   +1 more source

Correction: Impact of frailty and older age on weaning from invasive ventilation: a secondary analysis of the WEAN SAFE study. [PDF]

Ann Intensive Care
Laffey CM, Sheerin R, Khazaei O, McNicholas BA, Pham T, Heunks L, Bellani G, Brochard L, Tomescu D, Simpkin AJ, Laffey JG, WEAN SAFE Investigators.   +11 more
europepmc   +1 more source

Infrared illumination for difficult peripheral venous catheterisation in critically ill adult patients: the prospective, randomised, multicentre ICARE trial. [PDF]

BMJ Open
Ouedraogo R, Alves A, Bruant A, Sy O, Tabra Osorio C, Schortgen F, Chenal A, Contou D, Krzyzaniak L, Fartoukh M, Le Joncour M, Mongardon N, Ait Benaissa L, Da Silva D, Bouguerra M, Demeret S, Tanguy Dubois S, Starczala E, Petyt C, Schmidt M, Dezellus S, Georger JF, Pallud AC, Carras D, Boussely F, Audureau E, Mekontso Dessap A.   +26 more
europepmc   +1 more source

Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma. [PDF]

Blood Adv
Charton E, Anota A, Bachy E, Cartron G, Gros FX, Morschhauser F, Oberic L, Gastinne T, Feugier P, Dulery R, Thieblemont C, Joris M, Jardin F, Choquet S, Casasnovas O, Brisou G, Cheminant M, Bay JO, Llamas Gutierrez F, Portugues C, Itti E, Palard-Novello X, Blanc-Durand P, Al Tabaa Y, Bailly C, Laurent C, Lemonnier F, Houot R.   +27 more
europepmc   +1 more source

The therapeutic potential of low-intensity focused ultrasound for treating substance use disorder. [PDF]

Front Psychiatry
Olaitan GO, Lynch WJ, Venton BJ.
europepmc   +1 more source

Erratum: Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study. [PDF]

EClinicalMedicine
Bozonnat A, Beylot-Barry M, Dereure O, D'Incan M, Quereux G, Guenova E, Perier-Muzet M, Dalle S, Grange F, Viguier MA, Ram-Wolff C, Feldmeyer L, Beltraminelli H, Bonnet N, Amatore F, Maubec E, Franck N, Machet L, Chasset F, Brunet-Possenti F, Bouaziz JD, Battistella M, Donzel M, Pham-Ledard A, Bejar C, Moins-Teisserenc H, Mourah S, Saiag P, Hainaut E, Michel C, Bens G, Adamski H, Aubin F, Boulinguez S, Joly P, Tedbirt B, Templier I, Troin L, Montaudié H, Ingen-Housz-Oro S, Faiz S, Mortier L, Dobos G, Bagot M, Resche-Rigon M, Montlahuc C, Serret-Larmande A, de Masson A, Cutaneous Lymphomas French Study Group.   +48 more
europepmc   +1 more source

PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome. [PDF]

J Clin Med
Beck DB, Heiblig M, Savic S, Ferrada MA, Mekinian A, Chowdhury O, Hammond D, Weeks LD, Gurnari C, Kirino Y, Georgin-Lavialle S, Buckley SA, Garcha R, Harder BG, Koster MJ.   +14 more
europepmc   +1 more source

CHA₂DS₂-VASc scores to predict left atrial/left atrial appendage abnormalities in patients with sepsis-induced atrial fibrillation: A preliminary investigation. [PDF]

J Intensive Med
Labbé V, Ederhy S, Legouis D, Joffre J, Razazi K, Sy O, Chemouni F, Mekontso Dessap A, Fartoukh M, Cohen A.   +9 more
europepmc   +1 more source

Prevalence of thromboembolic events in critically-ill COVID-19 patients infected with Omicron: results from the French prospective, multicenter SEVARVIR cohort study. [PDF]

Crit Care
Bay P, Audureau E, Fourati S, de Prost N, SEVARVIR investigators.   +4 more
europepmc   +1 more source

Impact of COVID-19 infection in patients with inherited metabolic diseases: a National Multicenter Study from the French IMDs Healthcare Network for Rare Diseases. [PDF]

Orphanet J Rare Dis
Douillard C, Poujois A, Belmatoug N, Lidove O, Leguy-Seguin V, Mauhin W, Gorce M, Cano A, Labrune P, Mazodier K, Wicker C, Maillot F, Brassier A, Guemann AS, Habes D, Abi-Warde MT, Redonnet-Vernhet I, Germain DP, Lavigne C, Khemiri A, Mention K, Dao M, Héron B, Berger MG, Lonlay P.   +24 more
europepmc   +1 more source